Results 201 to 210 of about 33,112 (265)

Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopicdermatitis with clinical suspicion of secondary bacterial infection: anopen label uncontrolled study

, 2005
Kunal Khobragade
openalex   +1 more source

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]

JAMA
Weppner WG, Singh H, Boyd J, Smith G, Chesebro BB.   +4 more
europepmc   +1 more source

Azelastine-Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. [PDF]

Pharmaceuticals (Basel)
Indolfi C, Klain A, Dinardo G, Grella C, Di Filippo P, Fatica I, Napolano V, Decimo F, Miraglia Del Giudice M.   +8 more
europepmc   +1 more source

Comparative Effects of Anti-Inflammatory Therapies on Olfactory Bulb Histopathology and Olfactory Function in a Rat Model of Experimental Allergic Rhinitis. [PDF]

J Inflamm Res
Kayıkçı E, Kayıkçı H.
europepmc   +1 more source

A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis.

Health Technol Assess
Wilson N, Morton M, Homer T, Breeze Konkoth A, Joyce R, Kershaw A, Wilde H, Liddle A, Wason J, Ternent L, Allen M, Lord R, Steer J, Devereux G, Chalmers JD, Hill AT, Haworth CS, Hurst JR, De Soyza AA.   +18 more
europepmc   +1 more source

Orally Dispersible Swallowed Topical Corticosteroids in Eosinophilic Esophagitis: A Paradigm Shift in the Management of Esophageal Inflammation. [PDF]

Pharmaceutics
Barchi A, Girelli M, Ventimiglia A, Mandarino FV, Danese S, Passaretti S, Yacoub MR, Nannipieri S, Ciliberto AF, Albarello L, Bartolucci A, Vespa E, Dell'Anna G.   +12 more
europepmc   +1 more source

Real-World Safety and Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Asthma: Final Analysis of a Post-Marketing Surveillance in Japan. [PDF]

Adv Ther
Asai K, Morioka Y, Ito R, Komatsubara M, Maruoka H.   +4 more
europepmc   +1 more source

Explore impact of inhaled glucocorticoids/β₂-agonists on the oropharyngeal microbiota in asthma patients impact of GCs/β₂-agonists on oropharyngeal microbiota in asthma. [PDF]

Medicine (Baltimore)
Yang Y, Liu Y, Wang R, Liu J, Cui M, Duan Z.   +5 more
europepmc   +1 more source